Skip to content

Clinical trials

Phase 3 Carcinoma, Non-Small-Cell Lung trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 3 Country / region: New Zealand Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20062
20082
20092
20101
20121
20143
20152
20171
20181
20192
20202
20211
20231
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting6
Terminated5
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
Merck Sharp & Dohme LLC5
AbbVie2
Achieve Life Sciences1
BeiGene1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Canadian Cancer Trials Group1
Celgene1
Checkpoint Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung29
Lung Neoplasms7
Neoplasm Metastasis4
Carcinoma1
Colonic Neoplasms1
Rectal Neoplasms1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.